Trial Profile

Pharmacologic Optimization of Voriconazole - a Prospective Clustered Group-Randomized Cross-Over Trial of Therapeutic Drug Monitoring

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 10 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Voriconazole (Primary)
Indications Invasive bronchopulmonary aspergillosis
Focus Adverse reactions; Therapeutic Use

Most Recent Events

01 Feb 2023 Primary endpoint has not been met (response to treatment) , as per Results published in the International Journal of Antimicrobial Agents
01 Feb 2023 Results published in the International Journal of Antimicrobial Agents
12 Nov 2013 Planned end date changed from 1 Apr 2013 to 1 Jan 2015 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com